New England Journal of Medicine , “One Pivotal Trial, the New Default Option for FDA Approval – Ending the Two-Trial Dogma,” by Vinay Prasad, M.D., M.P.H.1 and Martin A. Makary, M.D., M.P.H.1
Read Publication
Annual report [Section 13 and 15(d), not S-K Item 405]
Current report
Definitive proxy statements
View and filter by group or type
